These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 8986799)
1. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Reiser J; Harmison G; Kluepfel-Stahl S; Brady RO; Karlsson S; Schubert M Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15266-71. PubMed ID: 8986799 [TBL] [Abstract][Full Text] [Related]
2. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432 [TBL] [Abstract][Full Text] [Related]
3. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Bovia F; Salmon P; Matthes T; Kvell K; Nguyen TH; Werner-Favre C; Barnet M; Nagy M; Leuba F; Arrighi JF; Piguet V; Trono D; Zubler RH Blood; 2003 Mar; 101(5):1727-33. PubMed ID: 12406892 [TBL] [Abstract][Full Text] [Related]
4. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis. Douglas JL; Lin WY; Panis ML; Veres G Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532 [TBL] [Abstract][Full Text] [Related]
5. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors. Barrette S; Douglas JL; Seidel NE; Bodine DM Blood; 2000 Nov; 96(10):3385-91. PubMed ID: 11071632 [TBL] [Abstract][Full Text] [Related]
6. Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Relander T; Johansson M; Olsson K; Ikeda Y; Takeuchi Y; Collins M; Richter J Mol Ther; 2005 Mar; 11(3):452-9. PubMed ID: 15727942 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094 [TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403 [TBL] [Abstract][Full Text] [Related]
9. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Reiser J Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549 [TBL] [Abstract][Full Text] [Related]
10. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Uchida N; Sutton RE; Friera AM; He D; Reitsma MJ; Chang WC; Veres G; Scollay R; Weissman IL Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11939-44. PubMed ID: 9751769 [TBL] [Abstract][Full Text] [Related]
11. Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity. Nack U; Schnierle BS Virology; 2003 Oct; 315(1):209-16. PubMed ID: 14592772 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. Strang BL; Takeuchi Y; Relander T; Richter J; Bailey R; Sanders DA; Collins MK; Ikeda Y J Virol; 2005 Feb; 79(3):1765-71. PubMed ID: 15650201 [TBL] [Abstract][Full Text] [Related]
13. Kinetic analyses of stability of simple and complex retroviral vectors. Higashikawa F; Chang L Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826 [TBL] [Abstract][Full Text] [Related]
14. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830 [TBL] [Abstract][Full Text] [Related]
15. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus. Federico M; Nappi F; Ferrari G; Chelucci C; Mavilio F; Verani P J Virol; 1995 Nov; 69(11):6618-26. PubMed ID: 7474070 [TBL] [Abstract][Full Text] [Related]
16. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562 [TBL] [Abstract][Full Text] [Related]
17. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192 [TBL] [Abstract][Full Text] [Related]
18. Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes. Mühlebach MD; Schmitt I; Steidl S; Stitz J; Schweizer M; Blankenstein T; Cichutek K; Uckert W J Mol Med (Berl); 2003 Dec; 81(12):801-10. PubMed ID: 14576928 [TBL] [Abstract][Full Text] [Related]
19. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185 [TBL] [Abstract][Full Text] [Related]
20. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays. Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]